VIRX

Viracta Therapeutics, Inc. Common Stock

Delisted

VIRX was delisted on the 3rd of February, 2025.

104 hedge funds and large institutions have $380M invested in Viracta Therapeutics, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
104
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$35.7M
Puts
$25.5M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
51
$652K
52
$631K
53
$577K
54
$536K
55
$520K
56
$509K
57
$506K
58
$491K
59
$460K
60
$443K
61
$354K
62
$343K
63
$313K
64
$290K
65
$286K
66
$277K
67
$274K
68
$266K
69
$246K
70
$218K
71
$213K
72
$210K
73
$198K
74
$193K
75
$191K